Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
OwnerDavid Gruber, Hung-Teh Kao +1inventors
InventorsDavid Gruber, Hung-Teh Kao, Vincent Pieribone
Life of this patent
Estimating the term…
Abstract
The present invention concerns novel isolated fluorescent proteins, variants thereof, and polynucleotides encoding the same. Methods for making and using the polypeptides and polynucleotides are also provided. For example, methods to detect protein-protein interactions, to develop novel fluorescent reagents, to monitor cellular events, as well as cell-based methods for screening for kinase or phosphatase inhibitors, are set forth. Kits to carry out the methods of the invention are also taught.
Claims39
An isolated fluorescent polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44.
An isolated fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.
An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
An isolated polynucleotide encoding a fluorescent polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44, wherein the isolated polynucleotide does not have a nucleotide sequence set forth in any of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
An isolated polynucleotide comprising a polynucleotide sequence having at least 85% sequence identity to SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 or 45.
An isolated polynucleotide encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, wherein the isolated polynucleotide does not have a polynucleotide sequence having at least 85% sequence identity to any of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
A fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44.
A fusion protein comprising an amino acid sequence of a protein of interest operatively joined to an amino acid sequence having at least 85% sequence identity to SEQ ID NO:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.
A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence selected from the group consisting of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 and 44, wherein the nucleotide sequence encoding the polypeptide does not have a nucleotide sequence set forth in any of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant has at least 85% sequence identity to SEQ ID NO:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44.
A polynucleotide comprising a nucleotide sequence encoding a protein of interest operatively linked to a nucleotide sequence encoding a fluorescent polypeptide variant, wherein the fluorescent polypeptide variant comprises at least 85% sequence identity to SEQ ID NO:
- 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42 or 44, wherein the nucleotide sequence encoding the fluorescent polypeptide variant does not have a nucleotide sequence having at least 85% sequence identity to any of SEQ ID NOS:
- 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45.
A method of screening for a compound that alters the activity of a protein kinase or phosphatase, comprising
- providing a cell which expresses said protein kinase or phosphatase and a fluorescent protein, wherein at least one fluorescent characteristic of said fluorescent protein changes upon phosphorylation by said kinase or dephosphorylation by said phosphatase;
- subjecting said cell to a candidate compound;
- detecting said fluorescent characteristic under conditions that permit phosphorylation of said fluorescent protein by said kinase or dephosphorylation by said phosphatase, and
- correlating the fluorescent characteristic detected with a determination that said candidate compound alters the activity of said protein kinase or phosphatase.
An isolated modified PhosFluor protein comprising at least one heterologous consensus sequence for phosphorylation by a protein kinase inserted into the amino acid sequence of SEQ ID NO:
- 10.
Dependencies are inferred from the claim text.